Patent · US Active

Formulation of contrast media and process of preparation thereof

US11944690B2 · kind B2 · utility

0Cited by
28References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2019
Grant dateApr 2, 2024
Priority date
Expiry dateMay 15, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K49/124
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a liquid pharmaceutical formulation comprising a DOSA-derived tetra-chelate of formula (I), in which M is an ion of a paramagnetic metal, preferably a Gd3+ ion, and R1, R2, R3, R4 and R5 are as defined in the claims, in a pharmaceutical acceptable solvent. The present disclosure also relates to a method of preparation of said liquid pharmaceutical formulation and to a method of imaging involving said liquid pharmaceutical formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.